AbbeyMoor updates Spanner stent design
This article was originally published in The Gray Sheet
FDA grants supplemental PMA approval for design changes to the prostatic stent aimed at increasing flexibility and patient comfort, AbbeyMoor Medical announces July 6. Spanner, a temporary stent that aids men experiencing difficulty urinating due to prostatic obstruction, received PMA approval in 2006. The device is marketed as an alternative to indwelling catheterization, intermittent catheterization or the use of a suprapubic tube
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.